New Venture Flow Chart

The New Venture Flow Chart is designed to help Vanderbilt faculty, investors, and venture capitalists understand the process of creating a new venture. This process begins with a detailed internal review of the technology and its likelihood for success, and advances to a more in-depth review that includes outside parties such as entrepreneurs, investors, and other key opinion leaders. CTTC will work closely with the faculty inventor and investors to ensure the process transitions smoothly. For more information, contact Peter Rousos, manager, economic/new business development. 

 

Featured Video

Vanderbilt-Ingram Cancer Center researchers have identified six subtypes of triple negative breast cancer which is often aggressive and difficult to treat. Now these cancer investigators are advancing their initial findings to clinical use by refining the molecular profiles for each cancer subtype, which will aid in the development of diagnostic tests for personalized therapy for patients.